Фостер Нeкстхалер

Фостер Некстхалер combines formoterol fumarate and beclometasone dipropionate for inhalation to support asthma and COPD management. This fixed-dose combination provides bronchodilation and anti-inflammatory effects in a single device. Suitable for adults and adolescents, it is designed for regular use as prescribed.

Фостер Некстхалер is used to control and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD) in adults and adolescents aged 12 years and older. It combines a long-acting beta-agonist (formoterol) for bronchodilation with an inhaled corticosteroid (beclometasone) to reduce airway inflammation. This combination helps maintain stable breathing patterns and reduce flare-ups when used regularly as directed.

Users typically report improved breathing comfort and reduced wheezing or shortness of breath during daily activities. The inhaler delivers medication directly to the lungs, which may help minimize systemic effects compared to oral treatments. Consistent use supports long-term control of respiratory symptoms and may reduce the need for rescue inhalers.

Store the inhaler at room temperature away from moisture and direct heat. Keep the device clean and dry; avoid dropping or immersing it in water. Always replace the cap after use to protect the mouthpiece. If the inhaler appears damaged or the dose counter is not working, discontinue use and consult a healthcare professional.

Caution is advised when using other inhaled medications, especially long-acting beta-agonists or high-dose corticosteroids. Avoid combining with non-selective beta-blockers, as they may reduce the effectiveness of formoterol. Inform your healthcare provider about all medications, including over-the-counter and herbal products, before starting use.